VINC - Why Is Cancer Focused Penny Stock Vincerx Pharma Trading Higher Today? | Benzinga
Vincerx Pharma Inc (NASDAQ: VINC) shares are trading higher after the company released clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for relapsed/refractory lymphoma.
Investigators reported two partial responses (PR) in three peripheral T-cell lymphoma (PTCL) patients and one PR in 2 double-hit diffuse large B-cell lymphoma (DH-DLBCL) patients in an ongoing dose-escalation trial of enitociclib in combination with venetoclax and ...